What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading higher by 20% to 17 cents during Monday's session after the company announced data on the potential mpox vaccine TNX-801 in the "Using Synthetic Biology To Battle Mpox" talk at an immunology symposium at the University of Alberta.
Tonix Pharmaceuticals Holding Corp (納斯達克:TNXP)股票在週一的交易中上漲20%，至17美分，因公司在阿爾伯塔大學的免疫學研討會上的"Using Synthetic Biology To Battle Mpox"講座中公佈了關於潛在的mpox疫苗TNX-801的數據。
What Happened: The presentation highlighted TNX-801, an attenuated live-virus horsepox vaccine designed to protect against mpox (formerly monkeypox).
發生了什麼事情：報告重點介紹了TNX-801，一種減毒活病毒馬痘疫苗，旨在預防mpox（以前稱爲猴痘）。
The company says TNX-801 offers single-dose protection and improved tolerability compared to 20th-century vaccines. It more closely resembles 19th-century vaccinia vaccines, which were effective against smallpox and long-lasting.
公司表示，與20世紀的疫苗相比，TNX-801提供了一次劑量的保護，並且具有更好的耐受性。它更接近於19世紀的牛痘疫苗，對天花有效且持久。
The company emphasized that TNX-801 could be more advantageous than existing mpox vaccines like ACAM2000 and Jynneos, offering better durability, fewer side effects, and simpler storage requirements.
公司強調，與現有的mpox疫苗ACAM2000和Jynneos相比，TNX-801可能更具優勢，具有更好的持久性，副作用更少，並且存儲要求更簡單。
Tonix says preclinical studies showed TNX-801 protects animals against lethal monkeypox challenges and reduces virus shedding, suggesting it could block transmission.
Tonix表示，臨床前研究顯示TNX-801可以保護動物免受致命猴痘挑戰的侵害，並降低病毒排放，暗示其可能阻斷傳播。
Tonix is meanwhile collaborating with Bilthoven Biologics to develop GMP manufacturing processes for TNX-801.
與Bilthoven Biologics合作，Tonix正在開發TNX-801的GMP生產工藝。
Read Also: Apple's iPhone 16 Launch: JPMorgan Says 'Staggered Pricing Approach' Could Offset Rising Chip, Memory Costs
閱讀更多：蘋果的iPhone 16發佈：摩根大通表示'分層定價方法'可以抵消不斷上漲的芯片和內存成本
How To Buy TNXP Stock
如何購買TNXP股票
By now you're likely curious about how to participate in the market for Tonix Pharmaceuticals – be it to purchase shares, or even attempt to bet against the company.
到目前爲止，您可能對如何參與Tonix Pharmaceuticals的市場感到好奇 - 無論是購買股票，還是試圖對該公司進行押注。
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy 'fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
通常是通過券商帳戶購買股票。您可以在此處找到可能的交易平台列表。許多平台將允許您購買「碎股」，這樣就可以擁有部分股票而無需購買整個股票。例如，某些股票，如伯克希爾哈撒韋（Berkshire Hathaway），可能需要支付數千美元才能擁有一股。但是，如果您只想投資一部分股票，券商將允許您這樣做。
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to 'go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
如果您想押注股票下跌，流程就更爲複雜了。您需要訪問期權交易平台，或者找一家券商讓您通過借出股票進行「開空」操作（借股出售）。您可以在該資源中了解到賣空股票的過程。否則，如果您的券商允許您交易期權，您可以在當前股票交易價以上的執行價上購買看跌期權或者賣出看漲期權 - 無論哪種情況都可以讓您從股票價格下跌中獲利。
According to data from Benzinga Pro, TNXP has a 52-week high of $29.76 and a 52-week low of $0.13.
根據Benzinga Pro的數據，TNXP的52周最高價爲$29.76，52周最低價爲$0.13。